by Team Small News | Jan 23, 2026 | Pharma
A batch of a multiple sclerosis (MS) medication has been recalled due to a manufacturing issue that affects the dissolution of the capsules. The medication, called Copaxone, is a glatiramer acetate injection used to treat relapsing forms of MS. The recall was... by Team Small News | Jan 23, 2026 | Lupin, Pharma
Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest ‘A’ leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change...
by Team Small News | Jan 23, 2026 | Pharma, Sun Pharma
Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to launch a generic version of Novo Nordisk’s Wegovy, a medication used to treat obesity. The approval comes as the patent for the active ingredient,... by Team Small News | Jan 22, 2026 | Alkem, Pharma
Alkem Laboratories, a prominent Indian pharmaceutical company, has received a Goods and Services Tax (GST) demand order from the Additional Commissioner, totaling ₹2.35 crore, along with a penalty. The order, which was issued on [date], has sparked concerns among the... by Team Small News | Jan 21, 2026 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has partnered with ImmunoACT, a biotech firm, to launch CAR-T cell therapy for the treatment of blood cancers in Africa. This collaboration aims to make this innovative and potentially life-saving treatment more accessible to... by Team Small News | Jan 20, 2026 | Pharma
The Delhi High Court has made a significant ruling in a trademark infringement case, stating that the use of letters “A” and “Z” cannot be monopolized by a single entity. The court refused an interim injunction sought by a company that claimed...